Growth Opportunities and Trends in the Gastroesophageal Reflux Disease (GERD) Market: Key Insights for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the CAGR of the Gastroesophageal Reflux Disease (GERD) Market Influence Its Overall Growth by 2034?
There has been a slight increase in the market size for gastroesophageal reflux disease (GERD) in the past years. The market is projected to expand from $5.25 billion in 2024 to $5.35 billion in 2025, with compound annual growth rate (CAGR) of 2.0%. Factors that have influenced the growth in the past include changes in lifestyle and diet, the increasing obesity crisis, heightened awareness towards GERD treatment, the global reach of the pharmaceutical industry, and investments into GERD therapy.
In the coming years, the market size for gastroesophageal reflux disease (GERD) is predicted to experience a steady growth, estimated at $5.94 billion by 2029 with a 2.7% compound annual growth rate (CAGR). The anticipated growth during the forecast period is linked to the aging populace, heightened healthcare costs, the discovery of biomarkers, increasing GERD screening programs, higher heartburn prevalence, and heightened demand for medical equipment. The forecast period is also expected to witness significant trends such as advancements in diagnostics and surgery, the introduction of targeted treatments, and the rising acceptance of telehealth services.
What Drivers Are Shaping the Growth of the gastroesophageal reflux disease (gerd) Market?
An increase in esophageal diseases is anticipated to fuel the expansion of the gastroesophageal reflux disease (GERD) market in the future. These diseases concern the esophagus, a muscular conduit that connects the mouth with the stomach. The medical treatment for these diseases aims at relieving symptoms, bettering the quality of life, and preventing any complications, thus ensuring enhanced overall health and well-being for those affected by gastroesophageal reflux disease. As an example, the American Cancer Society, a US-based professional organization, reported in January 2023 that roughly 21,560 fresh cases of esophageal cancer are diagnosed each year in the United States, resulting in 16,120 fatalities from the disease. As a result of the escalating frequency of esophageal diseases, the gastroesophageal reflux disease (GERD) market is experiencing steady growth.
Gastroesophageal Reflux Disease (GERD) Market Driver: Expansion of the Gastroesophageal Reflux Disease (GERD) Market due to Alcohol Consumption
Get Your Free Sample of the Global Gastroesophageal Reflux Disease (GERD) Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp
Who Are the Leading Companies Pioneering Change in the Gastroesophageal Reflux Disease (GERD) Market?
Major companies operating in the gastroesophageal reflux disease (GERD) market are:
• GlaxoSmithKline PLC_x000D_
• SRS Life Sciences_x000D_
• Johnson & Johnson Services Inc._x000D_
• Takeda Pharmaceutical Company Limited_x000D_
• AstraZeneca PLC_x000D_
What Are the Most Significant Trends Transforming the Gastroesophageal Reflux Disease (GERD) Market Today?
Prominent firms in the gastroesophageal reflux disease (GERD) market are centering their strategies on the unveiling of groundbreaking GERD treatment devices to maintain their dominant standing. For instance, Laborie Medical Technologies, an American medical technology firm, in April 2023 initiated the alpHaONE wireless pH-capsule reflux testing diagnostic apparatus engineered for detecting gastroesophageal reflux disease (GERD). The system is capable of providing up to 96 hours of monitoring data and introduces a compact design featuring enlarged buttons and a secure capsule delivery system. The system also includes a software application with a digital instruction module and user-customizable symptom buttons to enhance the user experience.
Get Instant Access to the Global Gastroesophageal Reflux Disease (GERD) Market Report with Swift Delivery!
Which Growth-Oriented Segments of the Gastroesophageal Reflux Disease (GERD) Market Are Leading the Industry’s Development?
The gastroesophageal reflux disease (GERD) market covered in this report is segmented –
1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist, EndoCinch, Stretta, EsophyX, Transoral Incisionless Fundoplication (TIF)
2) By Procedure: Invasive, Minimally Invasive
3) By End-Users: Hospital, Homecare, Specialty Clinics
Subsegments:
1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide
2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine
4) By Prokinetic Agents: Metoclopramide, Domperidone
5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol
6) By EndoCinch: Endoscopic Suturing Systems
7) By Stretta: Radiofrequency Ablation Systems
8) By EsophyX: Transoral Fundoplication Systems
9) By Transoral Incisionless Fundoplication (TIF): TIF Devices And Systems
Which Regions Are Leading the Charge in Gastroesophageal Reflux Disease (GERD) Market Development?
North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastroesophageal reflux disease (GERD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Key Elements Shape the Definition of the Gastroesophageal Reflux Disease (GERD) Market?
Gastroesophageal reflux disease (GERD) is a condition in which stomach acid flows back into the esophagus, causing irritation and discomfort. The treatment for the disease includes various medical strategies and interventions employed to manage the symptoms and complications associated with gastroesophageal reflux disease.
Browse Through More Similar Reports By The Business Research Company:
Inflammatory Bowel Disease Treatment Global Market Report 2024
Digestive Health Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digestive-health-global-market-report
Digestive Health Supplements Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digestive-health-supplements-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
